- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06842602
Evaluation of Gastric Volume and pH Changes in Gastroscopy Patients
April 14, 2025 updated by: Mehmet Fatih Erol, Bursa Yüksek İhtisas Education and Research Hospital
Evaluation of Gastric Volume and pH Changes in Gastroscopy Patients Using Chewing Gum and Candy: Prospective Randomized Double-Blind Study
Pulmonary aspiration is a rare but serious complication that can result in 57% mortality and 14% permanent damage.
Fasting rules (solid foods 6-8 hours, clear liquids 2 hours) determined by anesthesia associations are applied to prevent pulmonary aspiration by reducing gastric volume.
Gastric volume (≥ 0.5 mL/kg) and pH (<2.5) values are shown to be determinants in the occurrence of pulmonary complications .
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The hypothesis of this study was that preprocedure candy and chewing gum use may have no effects on gastric residual volume and pH.
For this purpose, we analyzed the gastric residual volume and gastric pH values of patients who were given gum and candy before the procedure.
Study Type
Interventional
Enrollment (Actual)
405
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bursa, Turkey, 16400
- Mehmet Fatih Erol
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ASA I-III,
- oriented
- cooperative
- scheduled for elective gastroscopy
Exclusion Criteria:
- body mass index is (BMI) >30 kg/m2,
- full stomach predicted patients (obstruction, stenosis, bleeding, ascites, urgency),
- patients with diabetes
- patients with who underwent bowel cleansing
- patients who did not want to give consent to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group control
strict fasting rules
|
followed strict fasting rules
|
|
Active Comparator: Group gum
chewed gum within 2 hours before the procedure
|
chewed gum within 2 hours before the procedure
|
|
Active Comparator: Group candy
consumed candy within 2 hours before the procedure
|
consumed candy within 2 hours before the procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastric volume
Time Frame: baseline
|
No washing was performed during the insertion and advancement of the endoscope.
The entire gastric volume were aspirated into a scaled container (medbar collection container).
The amount of collected samples was recorded .
|
baseline
|
|
Gastric pH measurements
Time Frame: baseline
|
No washing was performed during the insertion and advancement of the endoscope.
The entire gastric contents were aspirated into a scaled container (medbar collection container).
The amount of collected samples was recorded and pH analysis (WTW inoLab® pH 7310 Table Type pH Meter) was performed.
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
endoscopist satisfaction
Time Frame: baseline
|
At the end of the procedure, endoscopist satisfaction (0=unsatisfied 1=abstained 2=satisfied) and procedure difficulty (0=easy 1=normal 2=difficult)
|
baseline
|
|
general procedure satisfaction
Time Frame: baseline
|
Before discharge, general procedure satisfaction (0=unsatisfied, 1=abstained, 2=satisfied), product satisfaction (0=unsatisfied, 1=abstained, 2=satisfied), product effects (1=increase in hunger, 2=increase in thirst, 3=increase in dyspepsia, 4=abstained, 5= decrease in hunger, 6= decrease in thirst, 7= decrease in dyspepsia)
|
baseline
|
|
Complication
Time Frame: Perioperative
|
Perioperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Mehmet fatih erol, M.D, Bursa Yuksek ıhtısas tra
- Study Director: Füsun gözen, M.D, Bursa Yuksek Ihtısas tranin and research hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Actual)
August 1, 2023
Study Completion (Actual)
January 1, 2024
Study Registration Dates
First Submitted
February 19, 2025
First Submitted That Met QC Criteria
February 19, 2025
First Posted (Actual)
February 24, 2025
Study Record Updates
Last Update Posted (Actual)
April 15, 2025
Last Update Submitted That Met QC Criteria
April 14, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 2023/07-11
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastroscopy
-
Helsinki University Central HospitalCompleted
-
Herlev HospitalBispebjerg Hospital; University Hospital, Gentofte, CopenhagenCompleted
-
University Magna GraeciaNot yet recruiting
-
West China HospitalCompleted
-
University Health Network, TorontoCompleted
-
Erasme University HospitalCompletedDiagnostic GastroscopyBelgium
-
Ahon Pharmaceutical Co., Ltd.Not yet recruiting
-
Ahon Pharmaceutical Co., Ltd.CompletedColonoscopy | GastroscopyChina
-
Erasme University HospitalRecruitingDiagnostic GastroscopyBelgium
Clinical Trials on strict fasting rules
-
University Hospital, AngersCompleted
-
Vancouver Coastal HealthWithdrawnDiabetes Mellitus, Type 1 | Islet TransplantationCanada
-
Johns Hopkins UniversityCompletedUrinary Retention PostoperativeUnited States
-
Hospital Mutua de TerrassaRecruitingCeliac Disease | Villous Atrophy of IntestineSpain
-
University of Texas Southwestern Medical CenterWithdrawnRecurrent Brain Tumor, Childhood | Ketogenic DietUnited States
-
Alexa CraigMaineHealthCompletedPost-Op ComplicationUnited States
-
Children's Hospital of PhiladelphiaWithdrawnSepsis | Respiratory Failure | Trauma | Cardiovascular Failure
-
Centre Leon BerardRecruitingRadiation Toxicity | Radiation Dermatitis | Breast AdenocarcinomaFrance
-
The University of Texas Health Science Center,...National Institutes of Health (NIH)Terminated
-
University of California, San FranciscoTerminatedPilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD (PERFORMANCE)Hypertension | Chronic Kidney Disease | BloodpressureUnited States